{"university":{"openalex_id":"I103890011","name":"Shenyang Pharmaceutical University"},"topic":"age-crosslink-breakers","total_matching":2,"offset":0,"next_offset":null,"records":[{"doi":"https://doi.org/10.3390/molecules19067770","title":"Selective Substitution of 31/42–OH in Rapamycin Guided by an in Situ IR Technique","source_url":"https://doi.org/10.3390/molecules19067770","source_name":"Molecules","cited_by_count":8,"is_open_access":true,"openalex_work_id":"W1976663680","publication_date":"2014-06-10","publication_year":2014,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]},{"doi":"https://doi.org/10.1111/j.1745-7254.2005.00240.x","title":"C16, a novel advanced glycation endproduct breaker, restores cardiovascular dysfunction in experimental diabetic rats1","source_url":"https://doi.org/10.1111/j.1745-7254.2005.00240.x","source_name":"Acta Pharmacologica Sinica","cited_by_count":25,"is_open_access":false,"openalex_work_id":"W2154151258","publication_date":"2005-11-25","publication_year":2005,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]}],"automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}